Antimetabolites in combination with other drugs improve therapy of diffuse aggressive non-Hodgkin's lymphoma.
Odujinrin
O O
OO
Bertino
J R
JR
D000206:Actuarial Analysis; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use; D010865:Pilot Projects; D012306:Risk
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D008727:Methotrexate